Gelesis Investor Relations Material
Latest events
Q4 2022
Gelesis
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Gelesis Holdings Inc
Access all reports
Gelesis Holdings Inc. is a biotechnology company focused on developing products for weight management and metabolic health. The company creates therapeutics designed to treat obesity and other related conditions using hydrogel technology. Gelesis’ products are intended to aid in weight loss by creating a sensation of fullness, and they are based on its proprietary biomaterials platform. The company’s offerings target individuals seeking weight management solutions and those at risk of obesity-related health issues. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NYSE.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
GLS
Country
🇺🇸 United States